{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-001188","form_type":"8-K","ticker":"ABUS","cik":"0001447028","company_name":"Arbutus Biopharma Corp","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.649618+00:00","generated_at":"2026-05-25T17:24:50.311024+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Arbutus and Genevant file 5 international patent lawsuits against Moderna; terminate sublicense for breach","bullets":["Agreement entitles Arbutus to damages specifically allocated to Moderna's mRESVIA in pending U.S. litigation; if no allocation, parties discuss in good faith.","Arbutus terminated 2016 sublicense with ModernaTX for material breach over unpaid milestone/royalty payments; 60-day cure period.","Five lawsuits filed in Canada, Japan, Switzerland, and two UPC actions covering 30 countries, seeking injunctions and monetary relief against Spikevax and mRESVIA.","U.S. jury trial against Moderna in Delaware currently scheduled for September 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-001188","json":"https://secwatch.observer/filing/0001171843-25-001188.json","markdown":"https://secwatch.observer/filing/0001171843-25-001188.md","text":"https://secwatch.observer/filing/0001171843-25-001188.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447028/000117184325001188/0001171843-25-001188-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447028/000117184325001188/f8k_030325.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T17:24:50.311024+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}